Is Starlink Set For The Largest IPO In History?

He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000!

Joseph Pellegrino, Jr. Biography and Net Worth

CFO of LeMaitre Vascular

Joseph P. Pellegrino, Jr. has served as our Chief Financial Officer since 2007 and as a member of our Board of Directors since October 2016. Mr. Pellegrino joined us as our Executive Vice President, Finance, in 2005. From 1997 to 2003, Mr. Pellegrino worked at Zoots, Inc., a consumer services company founded by the founders of Staples, Inc., where most recently he served as Senior Vice President of Operations. Previously, Mr. Pellegrino built and sold a regional mall-based specialty retailing company. Mr. Pellegrino has also served as an investment banking analyst at Lehman Brothers, as part of their mergers and acquisitions group. Mr. Pellegrino is a director of Access Vascular, Inc., a medical device company focused on venous access devices. Mr. Pellegrino received an A.B. in Economics from Harvard College and an M.B.A. from the Harvard Business School. The Board has concluded that Mr. Pellegrino should serve on our Board due to his extensive knowledge of our business, his responsibility within the organization for our finances and his operational and financial experience gained with prior employers.

What is Joseph P. Pellegrino, Jr.'s net worth?: The estimated net worth of Joseph P. Pellegrino, Jr. is at least $585,131.88 as of February 29th, 2024. Mr. Pellegrino, Jr. owns 6,452 shares of LeMaitre Vascular stock worth more than $585,132 as of December 18th. This net worth evaluation does not reflect any other assets that Mr. Pellegrino, Jr. may own. Learn More about Joseph P. Pellegrino, Jr.'s net worth.
How do I contact Joseph P. Pellegrino, Jr.?: The corporate mailing address for Mr. Pellegrino, Jr. and other LeMaitre Vascular executives is 63 SECOND AVENUE, BURLINGTON MA, 01803. LeMaitre Vascular can also be reached via phone at (781) 221-2266. Learn More on Joseph P. Pellegrino, Jr.'s contact information.
Has Joseph P. Pellegrino, Jr. been buying or selling shares of LeMaitre Vascular?: Joseph P. Pellegrino, Jr. has not been actively trading shares of LeMaitre Vascular over the course of the past ninety days. Most recently, Joseph P. Pellegrino, Jr. sold 36,967 shares of the business's stock in a transaction on Thursday, February 29th. The shares were sold at an average price of $69.76, for a transaction totalling $2,578,817.92. Following the completion of the sale, the chief financial officer now directly owns 6,452 shares of the company's stock, valued at $450,091.52. Learn More on Joseph P. Pellegrino, Jr.'s trading history.
Who are LeMaitre Vascular's active insiders?: LeMaitre Vascular's insider roster includes Trent Kamke (Senior Vice President, Operations), George Lemaitre (Chairman & CEO), Joseph Pellegrino, Jr. (CFO), David Roberts (Director), and John Roush (Director). Learn More on LeMaitre Vascular's active insiders.
Are insiders buying or selling shares of LeMaitre Vascular?: In the last twelve months, insiders at the medical instruments supplier sold shares 14 times. They sold a total of 248,468 shares worth more than $18,596,775.26. The most recent insider tranaction occured on November, 15th when Director Bridget A Ross sold 3,750 shares worth more than $380,512.50. Insiders at LeMaitre Vascular own 10.8% of the company. Learn More about insider trades at LeMaitre Vascular.
Information on this page was last updated on 11/15/2024.

Joseph P. Pellegrino, Jr. Insider Trading History at LeMaitre Vascular

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/29/2024	Sell	36,967	$69.76	$2,578,817.92	6,452
8/9/2022	Sell	18,693	$53.99	$1,009,235.07	6,108
12/27/2021	Sell	807	$52.00	$41,964.00
11/25/2020	Sell	30,802	$41.35	$1,273,662.70	16,594
1/2/2020	Sell	710	$36.07	$25,609.70	11,021
12/30/2019	Sell	6,265	$36.11	$226,229.15	28,139
12/26/2019	Sell	1,412	$36.05	$50,902.60	28,139
12/18/2019	Sell	10,442	$36.10	$376,956.20	41,491
12/16/2019	Sell	6,068	$36.17	$219,479.56	41,491
12/5/2019	Sell	121,159	$34.93	$4,232,083.87
11/25/2019	Sell	64,792	$35.88	$2,324,736.96	211,878
11/22/2019	Sell	25,945	$35.09	$910,410.05	184,054
11/20/2019	Sell	11,182	$35.01	$391,481.82	184,054
9/23/2019	Sell	2,489	$35.09	$87,339.01	195,522
9/20/2019	Sell	23,905	$35.27	$843,129.35	195,522
8/23/2018	Sell	501	$37.03	$18,552.03	125,012
12/9/2015	Sell	14,348	$16.01	$229,711.48	110,389
11/23/2015	Sell	45,840	$15.57	$713,728.80	110,389
9/5/2013	Sell	25,000	$6.86	$171,500.00

Joseph P. Pellegrino, Jr. Buying and Selling Activity at LeMaitre Vascular

LeMaitre Vascular Company Overview

LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature. The company also provides artegraft biologic graft, a bovine carotid artery used for dialysis access; XenoSure biologic patches, used for closure of vessels after surgical intervention; VascuCel and CardioCel biologic patches, used in vessel repair, heart repair and reconstruction, and neonatal repairs; cardiovascular patches; carotid shunts that temporarily shunt the blood to the brain during the removal of plaque in a carotid endarterectomy surgery; biosynthetic vascular graft indicated for lower extremity bypass and dialysis access; and vascular grafts used to bypass or replace diseased arteries. In addition, it offers radiopaque tape, a medical-grade tape applied to the skin that enables surgeons and interventionalists to cross-refer between the inside and the outside of a patient's body and allows them to locate tributaries or lesions beneath the skin. Further, the company provides valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.

Today's Range

Now: $91.28

$90.69

$91.60

50 Day Range

MA: $97.71

$85.64

$107.97

2 Week Range

Now: $91.28

$52.88

$109.58

Volume

56,612 shs

Average Volume

129,057 shs

Market Capitalization

$2.05 billion

P/E Ratio

49.69

Dividend Yield

0.64%

Beta

0.93

Is Starlink Set For The Largest IPO In History?

From Paradigm Press | Ad

Click here now for the urgent details.